October 17, 2023
Company Description: Mitotech Ltd is a UK-based clinical stage biotechnology company developing mitochondria targeted drugs for a variety of neurodegenerative and metabolic diseases such as Obesity, NASH, Miltiple Sclerosis, Alzheimer's and Friedreich's Ataxia. Our products are based on a calss of novel small molecules that inhibit ferroptosis at the mitochondria level.
CEO/Top Company Official
Natalia Perekhvatova, CEO
Lead Product in Development
Oral formulation of SkQ1 - mitochondria targeted ferroptosis inhibitor - for treatment of NASH/Obesity, MS and Friedreich Ataxia
Development Phase of Primary Product